| |
 |
|
Class Information
Number: 424/189.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Hepatitis virus
Description: Subject matter wherein the virus is a hepatitis virus.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6372883 |
Antiviral medicaments |
Apr. 16, 2002 |
| 6368602 |
Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
Apr. 9, 2002 |
| 6355248 |
Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
Mar. 12, 2002 |
| 6355247 |
Nucleic acid immunization using a virus-based infection/transfection system |
Mar. 12, 2002 |
| 6346375 |
NANBV diagnostics and vaccines |
Feb. 12, 2002 |
| 6322789 |
HLA-restricted hepatitis B virus CTL epitopes |
Nov. 27, 2001 |
| 6319501 |
Method of immunizing against hepatitis B virus |
Nov. 20, 2001 |
| 6299874 |
Method of treatment |
Oct. 9, 2001 |
| 6300062 |
Enamel matrix related polypeptide |
Oct. 9, 2001 |
| 6297355 |
Polypeptides displaying HBV antigenicity or hbv antigen specificity |
Oct. 2, 2001 |
| 6287759 |
Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
Sep. 11, 2001 |
| 6284249 |
Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
Sep. 4, 2001 |
| 6280734 |
Simian-human HAV having a chimeric 2C protein |
Aug. 28, 2001 |
| 6270955 |
Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus |
Aug. 7, 2001 |
| 6270960 |
Recombinant antigen from the NS3 region of the hepatitis C virus |
Aug. 7, 2001 |
| 6268122 |
Recombinant DNA molecules and their method of production |
Jul. 31, 2001 |
| 6251654 |
Modified small RNA viruses |
Jun. 26, 2001 |
| 6235288 |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
May. 22, 2001 |
| 6235284 |
Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
May. 22, 2001 |
| 6231864 |
Strategically modified hepatitis B core proteins and their derivatives |
May. 15, 2001 |
| 6225458 |
Process for the production of DNA comprising the genome of the hepatitis B virus and vector including it |
May. 1, 2001 |
| 6221664 |
Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method |
Apr. 24, 2001 |
| 6217858 |
Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
Apr. 17, 2001 |
| 6217872 |
Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
Apr. 17, 2001 |
| 6210675 |
PT-NANB hepatitis polypeptides |
Apr. 3, 2001 |
| 6210901 |
Specific binding substances for antibodies and their use for immunoassays or vaccines |
Apr. 3, 2001 |
| 6165730 |
Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays |
Dec. 26, 2000 |
| 6153378 |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus |
Nov. 28, 2000 |
| 6153579 |
Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex |
Nov. 28, 2000 |
| 6150087 |
NANBV diagnostics and vaccines |
Nov. 21, 2000 |
| 6146643 |
Human/simian chimeric hepatitis A virus vaccine |
Nov. 14, 2000 |
| 6143715 |
Hepatitis C inhibitor peptide analogues |
Nov. 7, 2000 |
| 6136322 |
Hepatitis A virus deletion mutants and vaccine formulations containing the same |
Oct. 24, 2000 |
| 6136319 |
Method of treating viral diseases in animals |
Oct. 24, 2000 |
| 6121020 |
Hepatitis C E1 and E2 polypeptides and methods of obtaining the same |
Sep. 19, 2000 |
| 6117653 |
Hepatitis B surface antigen vaccine |
Sep. 12, 2000 |
| 6110706 |
Hepatitis B surface antigen vaccine |
Aug. 29, 2000 |
| 6110465 |
Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences |
Aug. 29, 2000 |
| 6100065 |
Hepatitis B surface antigen vaccine |
Aug. 8, 2000 |
| 6099840 |
Hepatitis B vaccine |
Aug. 8, 2000 |
| 6096319 |
Recombinant antigen from the NS3 region of the hepatitis C virus |
Aug. 1, 2000 |
| 6096879 |
Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process fo |
Aug. 1, 2000 |
| 6090388 |
Peptide composition for prevention and treatment of HIV infection and immune disorders |
Jul. 18, 2000 |
| 6072049 |
Hepatitis B surface antigen vaccine |
Jun. 6, 2000 |
| 6051238 |
Stabilizers for lyophilized mumps vaccines |
Apr. 18, 2000 |
| 6027729 |
NANBV Diagnostics and vaccines |
Feb. 22, 2000 |
| 6025141 |
Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
Feb. 15, 2000 |
| 6022543 |
Hepatitis B surface antigen vaccine |
Feb. 8, 2000 |
| 6020122 |
Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system |
Feb. 1, 2000 |
| 6020167 |
Composition used as a therapeutic agent against chronic viral hepatic diseases |
Feb. 1, 2000 |
|
|
|
